TLK1 serves as an upstream activator of NEK1>ATR>Chk1 [6,23], which has important implications during the early stages of prostate cancer (PCa) progression to androgen independence (AI) [24,25]. The gene discussed is CHEK1; the disease is posterior cortical atrophy.